BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Human Acellular Vessel (Humacyte) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Human Acellular Vessel (Humacyte)\, from 
 ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07078370-1249@assetmemo.bio
DTSTAMP:20261121T005026Z
DTSTART;VALUE=DATE:20270330
DTEND;VALUE=DATE:20270331
SUMMARY:Human Acellular Vessel (Humacyte): Phase na readout est. (NCT070783
 70)
DESCRIPTION:Human Acellular Vessel (Humacyte)\, phase na\, Atherosclerotic 
 Cardiovascular Disease.\nStudy: Safety Study of Acellular Tissue Engineere
 d Vessel for Coronary Artery Bypass\nEstimated primary completion: 30 Marc
 h 2027. This is a ClinicalTrials.gov estimate\, not a confirmed readout da
 te\, and it can move.\nDrug page: https://assetmemo.bio/drug/human-acellul
 ar-vessel-humacyte#upcoming-events\nRegistry record: https://clinicaltrial
 s.gov/study/NCT07078370
URL:https://assetmemo.bio/drug/human-acellular-vessel-humacyte#upcoming-eve
 nts
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05908084-1249@assetmemo.bio
DTSTAMP:20261121T005026Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:Human Acellular Vessel (Humacyte): Phase 3 readout est. (NCT0590808
 4)
DESCRIPTION:Human Acellular Vessel (Humacyte)\, phase 3.\nStudy: To Compare
  the Efficacy and Safety of the ATEV With AVF in Female Patients With End-
 Stage Renal Disease Requiring Hemodialysis\nEstimated primary completion: 
 June 2027. This is a ClinicalTrials.gov estimate\, not a confirmed readout
  date\, and it can move.\nDrug page: https://assetmemo.bio/drug/human-acel
 lular-vessel-humacyte#upcoming-events\nRegistry record: https://clinicaltr
 ials.gov/study/NCT05908084
URL:https://assetmemo.bio/drug/human-acellular-vessel-humacyte#upcoming-eve
 nts
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07762313-1249@assetmemo.bio
DTSTAMP:20261121T005026Z
DTSTART;VALUE=DATE:20281231
DTEND;VALUE=DATE:20290101
SUMMARY:Human Acellular Vessel (Humacyte): Phase 3 readout est. (NCT0776231
 3)
DESCRIPTION:Human Acellular Vessel (Humacyte)\, phase 3\, Vascular Trauma.\
 nStudy: An Open-label Study to Assess the Safety and Efficacy of SYMVESS®
  as a Vascular Conduit in Adolescents With Extremity Arterial Injury.\nEst
 imated primary completion: December 2028. This is a ClinicalTrials.gov est
 imate\, not a confirmed readout date\, and it can move.\nDrug page: https:
 //assetmemo.bio/drug/human-acellular-vessel-humacyte#upcoming-events\nRegi
 stry record: https://clinicaltrials.gov/study/NCT07762313
URL:https://assetmemo.bio/drug/human-acellular-vessel-humacyte#upcoming-eve
 nts
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07785661-1249@assetmemo.bio
DTSTAMP:20261121T005026Z
DTSTART;VALUE=DATE:20300831
DTEND;VALUE=DATE:20300901
SUMMARY:Human Acellular Vessel (Humacyte): Phase 1/2 readout est. (NCT07785
 661)
DESCRIPTION:Human Acellular Vessel (Humacyte)\, phase 1/2.\nStudy: A Study 
 Of Surgical Repair Of Discontinuous Branching Pulmonary Arteries\nEstimate
 d primary completion: 31 August 2030. This is a ClinicalTrials.gov estimat
 e\, not a confirmed readout date\, and it can move.\nDrug page: https://as
 setmemo.bio/drug/human-acellular-vessel-humacyte#upcoming-events\nRegistry
  record: https://clinicaltrials.gov/study/NCT07785661
URL:https://assetmemo.bio/drug/human-acellular-vessel-humacyte#upcoming-eve
 nts
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07762794-1249@assetmemo.bio
DTSTAMP:20261121T005026Z
DTSTART;VALUE=DATE:20300930
DTEND;VALUE=DATE:20301001
SUMMARY:Human Acellular Vessel (Humacyte): Phase 4 readout est. (NCT0776279
 4)
DESCRIPTION:Human Acellular Vessel (Humacyte)\, phase 4.\nStudy: Multicente
 r Study to Evaluate the Safety and Efficacy of SYMVESS™ in a Real World 
 Setting in Patients With Extremity Arterial Injury Requiring Urgent Repair
 \nEstimated primary completion: September 2030. This is a ClinicalTrials.g
 ov estimate\, not a confirmed readout date\, and it can move.\nDrug page: 
 https://assetmemo.bio/drug/human-acellular-vessel-humacyte#upcoming-events
 \nRegistry record: https://clinicaltrials.gov/study/NCT07762794
URL:https://assetmemo.bio/drug/human-acellular-vessel-humacyte#upcoming-eve
 nts
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
